N-Methyl-N-phenethyl-2-phenylethanamine, 95.0%, 100mg

rel-(1R,2S)-2-Aminocyclopentanecarboxamide hydrochloride, 97.0%, 500mg

(R)-3-(6-(2-((2,6-dichlorobenzyl)oxy)ethoxy)hexyl)-5-(2,2-dimethyl-4H-benzo[d][1,3]dioxin-6-yl)oxazolidin-2-one, 98%, 25mg

Imbuto separatore conico con rubinetto in PTFE 5000 ml

4-Amino-N-(tert-butoxycarbonyl)-L-phenylalanine>96.0%(HPLC)(T)1g

Zinc(II) 4-methylbenzenesulfonate hydrate, 98%, 1kg

D-4'-Tetrahydropyranylglycine, 97.0%, 10g

(R)-2-Amino-3-(7-methoxy-1H-indol-3-yl)propanoic acid, 97%, 50mg

2-(4-Iodophenyl)-3-(4-nitrophenyl)-5-phenyltetrazolium Chloride>98.0%(HPLC)(T)1g

(4R,5R)-4,5-Diphenyl-2-(5-(trifluoromethyl)pyridin-2-yl)-4,5-dihydrooxazole, 95%, 250mg

Colonna capillare per GC ROTI®Cap-5 MS, 12 m, 0.20 mm, 0.20 µm, 1 Pezzo(i)

3-Amino-2-bromopyridine>98.0%(GC)(T)5g

(5-Bromo-3-fluoropyridin-2-yl)methanol, 95.0%, 5g